Literature DB >> 9260894

Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein.

Y Lee1, Y Chen, L S Chang, L F Johnson.   

Abstract

The p53 tumor suppressor protein is an important negative regulator of the G1 to S transition in mammalian cells. We have investigated the effect of p53 on the expression of the mouse thymidylate synthase (TS) gene, which normally increases as cells enter S phase. A luciferase indicator gene that was driven by the wild-type or various modified forms of the TATA-less mouse TS promoter was transiently cotransfected with a p53 expression plasmid into TS-deficient hamster V79 cells and the level of luciferase activity was determined. We found that wild-type p53 inhibited TS promoter activity by greater than 95% but had a strong stimulatory effect on an artificial promoter that contained multiple p53-binding sites. In contrast, an expression plasmid that encodes a mutant form of p53 or a wild-type retinoblastoma tumor suppressor protein had little effect on TS promoter activity. Deletion of sequences upstream or downstream of the TS essential promoter region, or inactivation of each of the known elements within the essential promoter region, had no effect on the ability of wild-type p53 to inhibit TS promoter activity. Our observations indicate that the inhibition of TS promoter activity by p53 is not due to the presence of a specific p53 negative response element in the TS promoter. Rather, it appears that p53 inhibits the TS promoter by sequestering ("squelching") one or more general transcription factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260894     DOI: 10.1006/excr.1997.3605

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

Authors:  C J Di Como; C Gaiddon; C Prives
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  p53 Disruption Increases Uracil Accumulation in DNA of Murine Embryonic Fibroblasts and Leads to Folic Acid-Nonresponsive Neural Tube Defects in Mice.

Authors:  Erica R Lachenauer; Sally P Stabler; Martha S Field; Patrick J Stover
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

3.  Distinct p53 genomic binding patterns in normal and cancer-derived human cells.

Authors:  Krassimira Botcheva; Sean R McCorkle; W R McCombie; John J Dunn; Carl W Anderson
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

4.  Dose- and time-dependent expression patterns of zebrafish orthologs of selected E2F target genes in response to serum starvation/replenishment.

Authors:  Ceren Sucularli; Serif Senturk; Mehmet Ozturk; Ozlen Konu
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

Review 5.  Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?

Authors:  F Gieseler; P Rudolph; G Kloeppel; U R Foelsch
Journal:  Int J Colorectal Dis       Date:  2003-05-28       Impact factor: 2.571

6.  Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer.

Authors:  R Broll; P Busch; M Duchrow; E Oevermann; O Schwandner; S Farke; H P Bruch; U Windhövel
Journal:  Int J Colorectal Dis       Date:  2004-08-10       Impact factor: 2.571

7.  Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance.

Authors:  Sanjay Popat; Richard Wort; Richard S Houlston
Journal:  BMC Cancer       Date:  2006-06-05       Impact factor: 4.430

8.  Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma.

Authors:  N A Wong; L Brett; M Stewart; A Leitch; D B Longley; M G Dunlop; P G Johnston; A M Lessells; D I Jodrell
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

9.  Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.

Authors:  A Paradiso; G Simone; S Petroni; B Leone; C Vallejo; J Lacava; A Romero; M Machiavelli; M De Lena; C J Allegra; P G Johnston
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

10.  Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling.

Authors:  Agueda Buitrago-Pérez; Guillermo Garaulet; Ana Vázquez-Carballo; Jesús M Paramio; Ramón García-Escudero
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.